Operating income decreased 33.2%
Operating income changed -33.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -33.2% from the comparable as-filed period.
Net income changed -63.0% from the comparable as-filed period.
Gross margin changed -765 basis points from the comparable as-filed period.
Revenue changed +34.4% from the comparable as-filed period.
Cash & equivalents changed -66.8% from the comparable as-filed period.
Operating margin changed +136 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed +57.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory / revenue changed +2151 basis points from the comparable as-filed period.
SBC / revenue changed -915 basis points from the comparable as-filed period.
Stock-based compensation changed -21.6% from the comparable as-filed period.
Selling, general & administrative changed -12.8% from the comparable as-filed period.
Research & development changed -13.9% from the comparable as-filed period.
Gross profit changed +12.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.